Metabolic and endocrine studies in women using norethindrone acetate implant.

Abstract

Subcutaneously administered implant-D containing 40 mg of Norethindrone acetate in a single silastic implant was offered to 79 subjects who desired spacing of their family. The effect of constant release of steroid from this device on metabolic and endocrine functions was studied. Each subject in the pretreatment state served as her own control. The device… (More)

Topics

  • Presentations referencing similar topics